MedTrace Logo

Preoperative Percutaneous Radiofrequency Ablation of Primary and Secondary Lung Tumors

NCT00610844 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2008-02-20

No results posted yet for this study

Summary

The purpose of the study is to evaluate the effectiveness of radiofrequency ablation by pathological correlation and to characterize the tissue response after treatment of primary and secondary pulmonary tumors.

Conditions

Interventions

PROCEDURE

pulmonary radiofrequency ablation

CT-guided pulmonary radiofrequency ablation

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Philippe L Pereira, MD · Department of Diagnostic Radiology, University of Tübingen

  • Hermann Aebert, MD · Department of thoracic surgery, University of Tübingen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Primary Completion
2006-05-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00610844 on ClinicalTrials.gov